Andrea Bovolenta
Andrea Bovolenta was appointed in a total of 8 companies and resigned from 4 of these appointments.
Role
Director
Country Of Residence
United Kingdom
Nationality
Italian
Date of Birth
May 1972
Occupation
Finance Director
Active
4
Resigned
4
Dissolved
0
Other
0
Total
8
Companies
| Company | Timeline | Status | |
| Ethypharm UK Limited Director • Finance Director | 1 Mar 2024←1 Year 6 Months→Current | Active | |
| Viridian Pharma Limited Director • Finance Director | 1 Mar 2024←1 Year 6 Months→Current | Active | |
| Aurum Pharmaceuticals Limited Director • Finance Director | 1 Mar 2024←1 Year 6 Months→Current | Active | |
| Macarthys Laboratories Limited Director • Finance Director | 1 Mar 2024←1 Year 6 Months→Current | Active | |
| Ethypharm UK Limited Director • Finance Director | 1 Mar 2024←3 Months→5 Jun 2024 | Active | |
| Viridian Pharma Limited Director • Finance Director | 1 Mar 2024←3 Months→5 Jun 2024 | Active | |
| Aurum Pharmaceuticals Limited Director • Finance Director | 1 Mar 2024←3 Months→5 Jun 2024 | Active | |
| Macarthys Laboratories Limited Director • Finance Director | 1 Mar 2024←3 Months→5 Jun 2024 | Active | |
Mutual People
- Roseline Georgette JoannesseMacarthys Laboratories Limited, Viridian Pharma Limited, Aurum Pharmaceuticals Limited, and 1 more are mutual companies.
- Michael George LanningViridian Pharma Limited, Macarthys Laboratories Limited and Aurum Pharmaceuticals Limited are mutual companies
- David William WestAurum Pharmaceuticals Limited and are mutual companies.
- Mr Martin John SaundersMacarthys Laboratories Limited and Aurum Pharmaceuticals Limited are mutual companies.
- Jeremy Waring EarnshawAurum Pharmaceuticals Limited and Macarthys Laboratories Limited are mutual companies.
- Stephen David LofthouseMacarthys Laboratories Limited and Aurum Pharmaceuticals Limited are mutual companies.
Financials, Credit Activity, Owners, and more
Completely understand the businesses you work with
Make key decisions on clients and suppliers faster, discover leads and connect with decision makers, and easily monitor opportunities that get better through time
